Jose Manuel Otero, Chief Operating Officer at Lexeo Therapeutics, Inc. (LXEO), sold 1,304 shares at $4.96 ($6K) on 2026-08-18, disclosed to the SEC on 2026-08-19.
Open-market sale of $6k LXEO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LXEO | SELL | 2026-02-20 | $7K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $19K | — | Filing → |
| LXEO | SELL | 2025-11-20 | $7K | — | Filing → |